HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)’s earnings report is anticipated on March, 28., Zacks reports. earnings per share of $-0.19 is 26.67 % down from 2018’s $-0.15 EPS. Analysts at Wall Street see HTG Molecular Diagnostics, Inc.’s 11.76 % negative EPS growth compared to $-0.17 earnings per share for last quarter. The stock increased 0.73% or $0.02 during the last trading session, reaching $2.77.HTG Molecular Diagnostics, Inc. is uptrending after having risen 77.78% since March 3, 2018. HTGM has 338,312 volume or 1.31% up from normal. HTGM outperformed by 77.78% the S&P 500.
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Ratings Coverage
In total 2 analysts cover HTG Molecular Diagnostics (NASDAQ:HTGM). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. (NASDAQ:HTGM) has 100% bullish analysts. 2 are the (NASDAQ:HTGM)’s ratings reports on Mar 3, 2019 according to StockzIntelligence Inc. In Friday, February 22 report H.C. Wainwright maintained it with “Buy” rating and $8 target. On Wednesday, February 20 the stock of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) earned “Buy” rating by Cantor Fitzgerald.
HTG Molecular Diagnostics, Inc. develops and markets services and products based on proprietary technology that facilitates the routine use of targeted molecular profiling.The company has $78.93 million market cap. The company's products, HTG Edge and HTG EdgeSeq platforms include instrumentation , consumables comprising assay kits, and software analytics that automate sample processing and profiles various molecular targets from samples a fraction of the size required by prevailing technologies.Last it reported negative earnings. The Company’s platforms generate a molecular profiling library for detection using next-generation sequencing.
For more HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) news published recently go to: Benzinga.com, Nasdaq.com, Investingnews.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “5 Stocks To Watch For December 28, 2018 – Benzinga” published on December 28, 2018, “Health Care Sector Update for 03/24/2017: ADPT,HTGM,XENE – Nasdaq” on March 24, 2017, “5 Top NASDAQ Genetics Stocks Year-to-Date – Investing News Network” with a publish date: December 04, 2018, “HTG Molecular: Upside For This ~$3.50 ‘Busted IPO’? – Seeking Alpha” and the last “VIPS, CAR, DLPH and ATTU among notable midday movers – Seeking Alpha” with publication date: February 21, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.